ArticleJournal of cellular and molecular medicine2010

Cyclin A2 confers cisplatin resistance to endometrial carcinoma cells via up-regulation of an Akt-binding protein, periplakin.

Akihisa Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.